Bangkok Life Assurance Public Company Limited
BioGaia AB (publ), a healthcare company, develops, manufactures, markets and sells probiotic products for gut, oral, and immune health in Europe, the Middle East, Africa, the United States, the Asia-Pacific, Australia, and New Zealand. It operates through Pediatrics, Adult Health, and Other segments. The Pediatrics segment offers drops, oral rehydration solutions, and gut health tablets, as well … Read more
Bangkok Life Assurance Public Company Limited (BGLAF) - Net Assets
Latest net assets as of December 2025: $1.31 Billion USD
Based on the latest financial reports, Bangkok Life Assurance Public Company Limited (BGLAF) has net assets worth $1.31 Billion USD as of December 2025.
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets ($1.60 Billion) and total liabilities ($283.59 Million). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | $1.31 Billion |
| % of Total Assets | 82.25% |
| Annual Growth Rate | -5.53% |
| 5-Year Change | -30.0% |
| 10-Year Change | N/A |
| Growth Volatility | 12.44 |
Bangkok Life Assurance Public Company Limited - Net Assets Trend (2020–2025)
This chart illustrates how Bangkok Life Assurance Public Company Limited's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for Bangkok Life Assurance Public Company Limited (2020–2025)
The table below shows the annual net assets of Bangkok Life Assurance Public Company Limited from 2020 to 2025.
| Year | Net Assets | Change |
|---|---|---|
| 2025-12-31 | $1.31 Billion | -23.77% |
| 2024-12-31 | $1.72 Billion | -15.09% |
| 2023-12-31 | $2.03 Billion | +2.94% |
| 2022-12-31 | $1.97 Billion | +5.06% |
| 2021-12-31 | $1.88 Billion | +7.51% |
| 2020-12-31 | $1.75 Billion | -- |
Equity Component Analysis
This analysis shows how different components contribute to Bangkok Life Assurance Public Company Limited's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have decreased by 100.0% over the analyzed period, potentially due to dividend distributions or operating losses.
Current Equity Component Breakdown (December 2025)
| Component | Amount | Percentage |
|---|---|---|
| Other Components | $1.31 Billion | 100.00% |
| Total Equity | $1.31 Billion | 100.00% |
Bangkok Life Assurance Public Company Limited Competitors by Market Cap
The table below lists competitors of Bangkok Life Assurance Public Company Limited ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Yihai International Holding Ltd
PINK:YNNHF
|
$651.78 Million |
|
GB Group plc
PINK:GBGPF
|
$652.02 Million |
|
BUSINESS FIRST BANCSH.DL1
F:828
|
$652.09 Million |
|
Hellenic Petroleum S.A
PINK:HLPMF
|
$652.43 Million |
|
Usha Martin Limited
NSE:USHAMART
|
$651.30 Million |
|
Arendals Fossekompani ASA
OL:AFK
|
$651.20 Million |
|
Inspur Software Co Ltd
SHG:600756
|
$651.06 Million |
|
AICHI STEEL CORP.
F:8T2
|
$650.94 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Bangkok Life Assurance Public Company Limited's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2024 to 2025, total equity changed from 1,723,932,000 to 1,314,219,000, a change of -409,713,000 (-23.8%).
- Net income of 332,764,000 contributed positively to equity growth.
- Dividend payments of 698,020,000 reduced retained earnings.
- Other factors decreased equity by 44,457,000.
Equity Change Factors (2024 to 2025)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | $332.76 Million | +25.32% |
| Dividends Paid | $698.02 Million | -53.11% |
| Other Changes | $-44.46 Million | -3.38% |
| Total Change | $- | -23.77% |
Book Value vs Market Value Analysis
This analysis compares Bangkok Life Assurance Public Company Limited's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 0.74x
- The company is trading below its book value, potentially indicating the market believes the assets are overvalued on the balance sheet or anticipates future losses.
- The price-to-book ratio has increased from 0.55x to 0.74x over the analyzed period, suggesting growing market confidence.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2020-12-31 | $17.29 | $9.58 | x |
| 2021-12-31 | $18.59 | $9.58 | x |
| 2022-12-31 | $19.53 | $9.58 | x |
| 2023-12-31 | $20.11 | $9.58 | x |
| 2024-12-31 | $17.04 | $9.58 | x |
| 2025-12-31 | $12.99 | $9.58 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Bangkok Life Assurance Public Company Limited utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): 25.32%
- The company demonstrates strong efficiency in generating profits from shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: 21.63%
- • Asset Turnover: 0.96x
- • Equity Multiplier: 1.22x
- Recent ROE (25.32%) is above the historical average (17.23%), indicating improving capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2020 | 10.29% | 24.06% | 0.39x | 1.10x | $5.11 Million |
| 2021 | 10.45% | 25.00% | 0.37x | 1.13x | $8.54 Million |
| 2022 | 18.95% | 33.86% | 0.50x | 1.12x | $176.53 Million |
| 2023 | 17.99% | 28.18% | 0.56x | 1.15x | $162.32 Million |
| 2024 | 20.38% | 24.70% | 0.70x | 1.18x | $178.99 Million |
| 2025 | 25.32% | 21.63% | 0.96x | 1.22x | $201.34 Million |
Industry Comparison
This section compares Bangkok Life Assurance Public Company Limited's net assets metrics with peer companies in the Drug Manufacturers - Specialty & Generic industry.
Industry Context
- Industry: Drug Manufacturers - Specialty & Generic
- Average net assets among peers: $548,450,613
- Average return on equity (ROE) among peers: -450.37%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Bangkok Life Assurance Public Company Limited (BGLAF) | $1.31 Billion | 10.29% | 0.22x | $651.37 Million |
| Ascend Wellness Holdings Inc (AAWH) | $142.87 Million | -33.75% | 5.44x | $48.90 Million |
| AB Science S.A (ABSCF) | $10.73 Million | -252.65% | 3.71x | $39.89 Million |
| Alterola Biotech Inc (ABTI) | $4.85K | -2005.32% | 0.49x | $603.58K |
| Aurora Cannabis Inc (ACB) | $2.04 Billion | -34.08% | 0.34x | $199.15 Million |
| Acreage Holdings Inc (ACRDF) | $204.27 Million | -30.85% | 1.41x | $13.48K |
| Acura Pharmaceuticals Inc (ACUR) | $7.90 Million | -63.15% | 1.15x | $13.20K |
| Agra Ventures Ltd. (AGFAF) | $1.51 Million | -44.22% | 0.06x | $298.23K |
| Allergy Therapeutics plc (AGYTF) | $2.07 Million | -2084.75% | 31.32x | $25.30 Million |
| Aida Pharmaceuticals Inc (AIDA) | $6.67 Million | 24.51% | 2.78x | $1.80 |
| Adcock Ingram Holdings Limited (AIHLF) | $3.07 Billion | 20.55% | 0.55x | $85.61 Million |